HCA Healthcare, Inc. $HCA Stock Holdings Increased by Achmea Investment Management B.V.

Achmea Investment Management B.V. lifted its position in HCA Healthcare, Inc. (NYSE:HCA) by 47.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 77,557 shares of the company’s stock after acquiring an additional 25,042 shares during the quarter. Achmea Investment Management B.V.’s holdings in HCA Healthcare were worth $33,055,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Cerity Partners LLC grew its stake in HCA Healthcare by 13.1% during the 3rd quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock worth $18,719,000 after buying an additional 5,092 shares during the last quarter. Swiss National Bank grew its position in shares of HCA Healthcare by 4.3% during the second quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after acquiring an additional 23,100 shares during the last quarter. National Pension Service lifted its position in HCA Healthcare by 2.9% in the 3rd quarter. National Pension Service now owns 626,585 shares of the company’s stock valued at $267,051,000 after purchasing an additional 17,531 shares during the last quarter. Savant Capital LLC increased its stake in shares of HCA Healthcare by 37.7% in the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock valued at $1,938,000 after purchasing an additional 1,246 shares during the period. Finally, Sector Gamma AS boosted its position in shares of HCA Healthcare by 36.0% during the third quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock worth $4,638,000 after buying an additional 2,883 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. The Goldman Sachs Group boosted their price target on HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Royal Bank Of Canada lifted their price objective on shares of HCA Healthcare from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Wednesday, January 28th. Zacks Research cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. Robert W. Baird increased their price objective on shares of HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Finally, UBS Group upped their target price on HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research report on Monday, February 23rd. Sixteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $537.73.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction dated Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the sale, the executive vice president owned 30,003 shares of the company’s stock, valued at $14,944,194.27. This represents a 4.76% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Michael R. Mcalevey sold 1,694 shares of the business’s stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the transaction, the executive vice president directly owned 8,853 shares of the company’s stock, valued at approximately $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 15,214 shares of company stock worth $7,797,595. 1.30% of the stock is owned by company insiders.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $510.34 on Wednesday. The stock has a market capitalization of $114.10 billion, a price-to-earnings ratio of 17.98, a price-to-earnings-growth ratio of 1.61 and a beta of 1.34. The business’s fifty day moving average price is $508.54 and its two-hundred day moving average price is $472.06. HCA Healthcare, Inc. has a fifty-two week low of $314.43 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping the consensus estimate of $7.37 by $0.64. The business had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be given a dividend of $0.78 per share. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 10.15%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.